AURINIA
Aurinia Pharmaceuticals Inc.
Application Filed: 2017-09-12
Trademark Application Details
SUSPENSION INQUIRY - MAILED
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87604403 |
| Registration Number | 6430762 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Domestic Representative | Matthew R. Wilmot |
| Attorney Name | Matthew R. Wilmot |
| Law Office Assigned | O30 |
| Employee Name | DYER, ERIN ZASKODA |
Timeline
| 2017-09-12 | Application Filed |
| 2019-10-21 | Status: Live/Pending |
| 2019-11-25 | Location: TMO LAW OFFICE 130 - EXAMINING ATTORNEY ASSIGNED |
| 2019-11-25 | Transaction Date |
| 2021-07-27 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  Aurinia Pharmaceuticals Inc. |
| Address | 1203-4464 Markham Street Victoria, British Columbia V8Z 7X8 CA |
| Legal Entity Type | Company |
| Legal Entity State | CA |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations for the treatment of autoimmune disorders, kidney disorders, opthamalogical disorders and lupus nephritis |
| GS0051 | (Based on 44(e)) Pharmaceutical preparations for the treatment of autoimmune disorders, kidney disorders, opthamalogical disorders and lupus nephritis |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2017-09-15 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2017-09-16 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2017-12-15 | 3 DOCK D:Assigned to Examiner |
| SUSPENSION LETTER WRITTEN | 2017-12-16 | 4 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2017-12-16 | 5 GNSL F:First Action |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2017-12-16 | 6 GNS3 O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2018-07-13 | 7 ALIE A:Allowance for Publication |
| LIE CHECKED SUSP - TO ATTY FOR ACTION | 2018-07-16 | 8 RCCK S: |
| SUSPENSION INQUIRY WRITTEN | 2018-08-04 | 9 CNSI R:Renewal |
| INQUIRY TO SUSPENSION E-MAILED | 2018-08-04 | 10 GNSI S: |
| NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | 2018-08-04 | 11 GNS2 O:Outgoing Correspondence |
| TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2019-01-30 | 12 ERSI I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-02-01 | 13 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-02-01 | 14 TEME I:Incoming Correspondence |
| SUSPENSION LETTER WRITTEN | 2019-02-25 | 15 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2019-02-25 | 16 GNSL S: |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2019-02-25 | 17 GNS3 O:Outgoing Correspondence |
| LIE CHECKED SUSP - TO ATTY FOR ACTION | 2019-09-27 | 18 RCCK S: |
| SUSPENSION INQUIRY WRITTEN | 2019-10-21 | 19 CNSI R:Renewal |
| INQUIRY TO SUSPENSION E-MAILED | 2019-10-21 | 20 GNSI S: |
| NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | 2019-10-21 | 21 GNS2 O:Outgoing Correspondence |
| TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2020-04-13 | 22 ERSI I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2020-04-13 | 23 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2020-04-14 | 24 TEME I:Incoming Correspondence |
| SUSPENSION LETTER WRITTEN | 2020-05-06 | 25 CNSL R:Renewal |
| LETTER OF SUSPENSION E-MAILED | 2020-05-06 | 26 GNSL S: |
| NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | 2020-05-06 | 27 GNS3 O:Outgoing Correspondence |
| LIE CHECKED SUSP - TO ATTY FOR ACTION | 2020-11-12 | 28 RCCK S: |
| SUSPENSION INQUIRY WRITTEN | 2020-12-04 | 29 CNSI R:Renewal |
| INQUIRY TO SUSPENSION E-MAILED | 2020-12-04 | 30 GNSI S: |
| NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED | 2020-12-04 | 31 GNS2 O:Outgoing Correspondence |
| TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | 2021-03-30 | 32 ERSI I:Incoming Correspondence |
| ASSIGNED TO LIE | 2021-04-01 | 33 ALIE A:Allowance for Publication |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2021-04-06 | 34 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2021-04-06 | 35 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-04-06 | 36 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-04-21 | 37 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2021-05-11 | 38 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-05-11 | 39 NPUB E:E-Mail |
| REGISTERED-PRINCIPAL REGISTER | 2021-07-27 | 40 R.PR A:Allowance for Publication |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 AURINIA 88864257 not registered Live/Pending |
Aurinia Pharmaceuticals Inc. 2020-04-08 |
 AURINIA 87604403 not registered Live/Pending |
Aurinia Pharmaceuticals Inc. 2017-09-12 |
 AURINIA 87604400 not registered Live/Pending |
Aurinia Pharmaceuticals Inc. 2017-09-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 